Seattle, March 11, 2003 - Corixa Corporation (Nasdaq: CRXA), a developer of immunotherapeutics, today announced the appointment of Vaughn B. Himes, Ph.D., as Vice President, Worldwide Manufacturing.Dr. Himes
brings to Corixa
over 15 years of commercial experience in product development, process sciences and cGMP manufacturing operations.As a member of Corixa's management team, Dr. Himes will provide strategic direction and leadership in the development and implementation of company-wide manufacturing policies and programs.Dr. Himes will oversee production activities at Corixa's Montana facility as well as manufacturing for all products in clinical trials.
...Prior to his appointment at Corixa, Dr. Himes held the position of Vice President, Manufacturing Operations at Targeted Genetics.While at Targeted Genetics, Dr. Himes directed manufacturing operations, quality control, materials management and contract manufacturing for gene delivery products.He managed the technology transfer of large-scale cell culture-based processes to manufacturing, cGMP manufacturing, formulation/fill, in-process and final product release testing, CMC preparation, product and process related regulatory support as well as facilities planning, design and build-out. Prior to Targeted Genetics, Dr. Himes was Associate Director, Biological Development at Wyeth-Lederle Vaccines (now Wyeth), where he managed the process development, scale-up, clinical production, technology transfer and product licensure for cell culture-based viral vaccines.